{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:59:25Z","timestamp":1788490765469,"version":"build-2803163510"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,9,2]]},"abstract":"ABSTRACT<\/jats:title>\n \n \n \n This prospective, cross-sectional study was undertaken to identify the emerging\n K. pneumoniae<\/jats:italic>\n phylogeny groups (KpI, KpII, KpIII) and characterize their drug resistance. Phylogeny groups of 150 clinical isolates of biochemically identified\n K. pneumoniae<\/jats:italic>\n were detected by targeting their chromosomal class A, \u03b2-lactamase genes\n bla<\/jats:italic>\n SHV<\/jats:sub>\n ,\n bla<\/jats:italic>\n LEN<\/jats:sub>\n , and\n bla<\/jats:italic>\n OKP<\/jats:sub>\n , respectively, and their flanking gene (\n deoR<\/jats:italic>\n ). Antimicrobial susceptibility testing was done by disk diffusion and broth microdilution methods and statistically analyzed. Carbapenemases (Classes A, B, and D) were detected by multiplex PCR. Colistin resistance mechanisms to detect alteration in\n PhoP<\/jats:italic>\n \/\n PhoQ<\/jats:italic>\n ,\n pmrAB<\/jats:italic>\n two-component signaling pathways, and\n mgrB<\/jats:italic>\n were done by PCR and sequencing. Of the total, KpI,\n K. pneumoniae<\/jats:italic>\n were 93 (62%), KpII,\n K. quasipneumoniae<\/jats:italic>\n were 36 (24%), and KpIII,\n K. variicola<\/jats:italic>\n were 21 (14%). Carbapenem resistance was in 77 (51.3%); 52 (55.9%), 17 (47.2%), and 8 (38%) in KpI, KpII, and KpIII, respectively. Colistin resistance was in 16 (10.6%), 11 (68.75%) in KpI and 5 (31.25%) in KpIII.\n K. variicola<\/jats:italic>\n was resistant to polymyxin B as compared with KpI (\n P<\/jats:italic>\n = 0.0008).\n bla<\/jats:italic>\n NDM<\/jats:sub>\n (63, 81.8%) was the commonest. Co-harboring of multiple carbapenemase genes was significant in all the phylogroups (\n P<\/jats:italic>\n < 0.001). The majority of the cases of\n K. variicola<\/jats:italic>\n were males (\n P<\/jats:italic>\n = 0.0139) and in the intensive care unit (\n P<\/jats:italic>\n = 0.0091). Several non-synonymous mutations were observed in the colistin-resistant isolates in\n PhoP<\/jats:italic>\n and\n PhoQ<\/jats:italic>\n genes, with the phylogenetic tree revealing different evolutionary relationships among the isolates. There is considerable emergence of\n K. quasipneumoniae<\/jats:italic>\n and\n K. variicola<\/jats:italic>\n as prominent human pathogens along with drug resistance, which requires attention.\n <\/jats:p>\n \n IMPORTANCE<\/jats:title>\n \n These epidemiological data add to the extremely scarce literature on the occurrence of the two phylogeny groups of\n K. pneumoniae<\/jats:italic>\n , namely\n K. quasipneumoniae<\/jats:italic>\n and\n K. variicola<\/jats:italic>\n , in infections and highlight their widespread dissemination as prominent human pathogens, beyond agriculture and environment as their common habitat. There was significant drug resistance in the phylogeny groups, including colistin resistance in\n K. variicola<\/jats:italic>\n , which was studied for the first time.\n <\/jats:p>\n <\/jats:sec>\n <\/jats:sec>","DOI":"10.1128\/spectrum.00198-25","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:00:36Z","timestamp":1754658036000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Emergence of drug-resistant\n Klebsiella pneumoniae<\/i>\n phylogroups (\n K. quasipneumoniae<\/i>\n and\n K. variicola<\/i>\n ) causing human infections"],"prefix":"10.1128","volume":"13","author":[{"given":"Kajal","family":"Mishra","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-2842","authenticated-orcid":true,"given":"Tuhina","family":"Banerjee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Yadav","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Paediatrics, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Pratap","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Chaurasiya","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pue","family":"Rakshit","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University","place":["Varanasi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 2020. Antimicrobial resistance: Klebsiella Pneumoniae. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240082496. Retrieved 12 Nov 2024."},{"key":"e_1_3_3_3_2","unstructured":"World Health Organization. 2024. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. Available from: https:\/\/www.who.int\/news\/item\/17-05-2024"},{"key":"e_1_3_3_4_2","unstructured":"World Health Organization2021. New indian priority pathogen test to guide discovery of effective antibiotics. Available from: https:\/\/dbtindia.gov.in\/ latest-announcement\/indian-priority-pathogen-list-jointly-developed-dbt-and-who-india-office"},{"key":"e_1_3_3_5_2","unstructured":"Centers for Disease Control and Prevention. 2020. Antibiotic resistance threats in the United States: Klebsiella Pneumoniae. Available from: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.02.020"},{"key":"e_1_3_3_7_2","unstructured":"National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). 2020. Annual report. Available from: https:\/\/www.cdc.gov\/ narms\/reports\/healthy-people-2020.html"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1157010"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2019.1634981"},{"key":"e_1_3_3_10_2","first-page":"339","article-title":"Klebsiella variicola, a new species from human and animal sources","volume":"36","author":"Brisse S","year":"2013","unstructured":"Brisse S, Passet V, Grimont PA. 2013. Klebsiella variicola, a new species from human and animal sources. Syst Appl Microbiol 36:339\u2013346. https:\/\/doi.org\/ 10.1099\/ijs.0.062737-0.","journal-title":"Syst Appl Microbiol"},{"key":"e_1_3_3_11_2","unstructured":"Crichton PB. 1996. \u201cEnterobacteriaceae: Escherichia Klebsiella Proteus and other genera\u201d in Mackie and McCartney practical medical microbiology p 361\u2013364. In Collee EdsJG Mackie TJ McCartney JE (ed) 14th ed. London UK."},{"key":"e_1_3_3_12_2","volume-title":"Performance standard for antimicrobial susceptibility","author":"Clinical Laboratory Standard Institute","year":"2023","unstructured":"Clinical Laboratory Standard Institute. 2023. Tests for colistin resistance in Enterobactarales. In Performance standard for antimicrobial susceptibility, M07-A13, 33rd ed. Clinical Laboratory Standard Institute, Wayne, PA.","edition":"07"},{"key":"e_1_3_3_13_2","volume-title":"Performance standard for antimicrobial susceptibility","author":"Clinical Laboratory Standard Institute","year":"2023","unstructured":"Clinical Laboratory Standard Institute. 2023. Introduction to tables 3B and 3C page no. 152.Test for carbapenems in Enterobacterales. In Performance standard for antimicrobial susceptibility, M07-A13, 33rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"07"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"e_1_3_3_15_2","volume-title":"Appendix C quality control strains for antimicrobial susceptibility tests page no. 290","author":"Clinical Laboratory Standard Institute","year":"2023","unstructured":"Clinical Laboratory Standard Institute. 2023. Appendix C quality control strains for antimicrobial susceptibility tests page no. 290. M07-A13, 33rd edition ed. Clinical Laboratory Standard Institute, Wayne, PA.","edition":"07"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.01.005"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2012.32.5.359"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.12.002"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku256"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.200900"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.1.8-13.2001"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz455"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky27"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02481-18"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S369934"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113539"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4498-x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00475-16"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphereDirect.00290-17"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02513-18"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-021-00630-z"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/39634.1311"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz314"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00198-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00198-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:05:08Z","timestamp":1756818308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00198-25"}},"subtitle":[],"editor":[{"given":"Bobby G.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1128\/spectrum.00198-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00198-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"2025-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00198-25"}}